Canada markets close in 4 hours 6 minutes

Medicenna Therapeutics Corp. (MDNA.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.7000+0.2600 (+10.66%)
As of 11:54AM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 182.46M
Enterprise Value 160.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.79
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -9.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3139.22%
S&P500 52-Week Change 325.77%
52 Week High 32.7000
52 Week Low 30.2150
50-Day Moving Average 31.6747
200-Day Moving Average 30.7771

Share Statistics

Avg Vol (3 month) 3179.03k
Avg Vol (10 day) 3205.42k
Shares Outstanding 574.78M
Implied Shares Outstanding 674.78M
Float 846.09M
% Held by Insiders 122.05%
% Held by Institutions 17.29%
Shares Short (Apr 30, 2024) 487.92k
Short Ratio (Apr 30, 2024) 40.37
Short % of Float (Apr 30, 2024) 40.42%
Short % of Shares Outstanding (Apr 30, 2024) 40.12%
Shares Short (prior month Mar 28, 2024) 4136.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 03, 2017
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.57%
Return on Equity (ttm)-59.47%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.99M
Net Income Avi to Common (ttm)-15.42M
Diluted EPS (ttm)-0.2300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.76M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.00
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-13.71M
Levered Free Cash Flow (ttm)-9.5M